Palamidessi takes 0.25-mg doses of retatrutide twice a week for eight weeks at a time, with four-week breaks in between
In the GLP-1 RA vs DPP-4 inhibitor cohort, GLP-1 RA use was associated with lower risk among patients with recent psychiatric history, and no difference among patient without recent psychiatric history
Cardiovasc Diabetol 23 , 242 (2024)
The global health and economic burden of hospitalizations for heart failure: lessons learned from hospitalized heart failure registries
Its not about chasing trends
By introducing new medications and forming collaborations with different caregivers, weve seen real results people feel better and avoid hospitalizations, said Tony Bashall, MD, an Indianapolis cardiologist at Franciscan Health Indiana Heart Physicians with an interest in cardiometabolic health